Kejing Tang - Publications, H-index & Citations

Kejing Tang

sun yat-sen university

31H指数

265论文数

3.9K被引数

收录论文 73

发表时间

Models Integrating Disease Heterogeneity and MPA Exposure Predict Systemic and Renal Efficacy of Mycophenolate in Pediatric Lupus Nephritis 整合疾病异质性和MPA暴露的模型预测霉酚酸在儿童狼疮肾炎中的全身和肾效能

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

IF0

2026-03-09

PREAI

Baojing Liu; Lizhi Chen; Jingxuan Lin; Xiaoman Liu; Xiaohong Liu; Zhijun Huang; Min Huang; Kejing Tang; Xiaoyun Jiang; Pan Chen

Clonal architecture of FLT3-ITD and acquired 13q uniparental disomy define prognostic heterogeneity and therapeutic vulnerabilities in acute myeloid leukemia FLT3-ITD的克隆结构和获得性13q单亲二倍体的定义了急性髓系白血病中的预后异质性和治疗易损性。

Neoplasia

IF7.7

2025-12-17

OAAI

Anli Lai; Wenbing Liu; Yihan Mei; Qimin Zhang; Junping Zhang; Kejing Tang; Qing Rao; Runxia Gu; Sizhou Feng; Ying Wang; Min Wang; Hui Wei; Yingchang Mi; Shaowei Qiu; Jianxiang Wang

CircRNF10 sequestrates β-catenin by a dual regulatory circuit of direct degradation and a miR-1275/DKK3-mediated inhibition in driver gene- negative lung adenocarcinoma 在驱动基因阴性的肺腺癌中，CircRNF10通过直接降解和miR-1275/DKK3-mediated抑制的双重调节回路隔离 β-catenin

Molecular Cancer

IF33.9

2025-12-05

OAAI

Xiaohua Situ; Xinwei Wang; Xiting Liao; Xiaoxuan Zhang; Sicheng Chen; Fei Fang; Lihong Wei; Peng Wu; Zhiyu Liu; Honglei Chen; Kejing Tang; Lihong Bai; Zunfu Ke

Real-world use of and clinical outcomes with dacomitinib as first-line therapy in Asian patients with EGFR mutation–positive locally advanced or metastatic non-small cell lung cancer: Final analysis of the ARIA study 达可替尼作为亚洲表皮生长因子受体（EGFR）突变阳性局部晚期或转移性非小细胞肺癌患者的一线疗法：ARIA研究的最终分析

Lung Cancer

IF4.4

2025-11-25

PREAI

Lin Wu; Junling Li; Chong-Rui Xu; Bivas Biswas; Somnath Roy; Ke-Jing Tang; Huijuan Wang; Ziling Liu; Ullas Batra; Gwo Fuang Ho; John Low Seng Hooi; You Lu; Mingfang Zhao; Lye Mun Tho; Jun Zhao; Shan He; Joan Huang; Hui Zhang; Chew Hooi Wong; Yi-Long Wu

Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study Amivantamab-化疗在EGFR外显子20插入的非小细胞肺癌中的应用：来自III期PAPILLON研究的治疗交叉和其他终点的影响

Targeted Oncology

IF4

2025-11-03

OAAI

Rachel E. Sanborn; Caicun Zhou; Ke-Jing Tang; Byoung Chul Cho; Susanna Cheng; Sanjay Popat; Akira Ono; Shun Lu; Margarita Majem; Andres Aguilar; Maria Del Rosario Garcia Campelo; Hidetoshi Hayashi; Kang-yun Lee; Se-Hoon Lee; Angelo Delmonte; Jorge Alatorre-Alexander; Gary Richardson; Victor Santos; Christophe Dooms; Joshua K. Sabari; Catherine A. Shu; Nicolas Girard; Aaron S. Mansfield; Keunchil Park; Yichuan Xia; Archan Bhattacharya; Nasuh Buyukkaramikli; Nolen Perualila; Joris Diels; Sandip Acharya; Conor Chandler; Irina Proskorovsky; Lindsay Dearden; Honeylet Wortman-Vayn; Parthiv J. Mahadevia; Roland E. Knoblauch; Trishala Agrawal; Mahadi Baig; Enriqueta Felip

EP.17.09 Pulmonary Nodule Burden in Melbourne: A Snapshot Pre-Australian Lung Cancer Screening Rollout EP.17.09 墨尔本肺结节负担：澳大利亚肺癌筛查计划启动前的横断面研究

Journal of Thoracic Oncology

IF20.8

2025-10-23

PREAI

C.L. Leong; K. Tang; A. Hocking; M. Yao; H. Buzacott; A. Baker; S. Knight; T. Leong

Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial Ivonescimab 联合化疗与 tislelizumab 联合化疗作为晚期鳞状非小细胞肺癌的一线治疗（HARMONi-6）：一项随机、双盲、Ⅲ期临床试验

The Lancet

IF97.3

2025-10-19

PREAI

Zhiwei Chen; Fang Yang; Zhou Jiang; Longhua Sun; Lin Wu; Zhengxiang Han; Yun Fan; Yanqiu Zhao; Xingya Li; Haipeng Xu; Xiangjiao Meng; Ying Liu; Zhiye Zhang; Hui Luo; Xuelei Ma; Xuezhen Ma; Qin Shi; Zhongmin Zhang; Runxiang Yang; Pingli Wang; Pinhua Pan; Xiaohong Ai; Jie Li; Xingxiang Pu; Zhiwu Wang; Jian Fang; Ming He; Yong He; Shuliang Guo; Juan Li; Hongbiao Wang; Junqiang Zhang; Qian Chu; Xuewen Liu; Shenpeng Ying; Hongcheng Wu; Hongmei Sun; Yinghua Ji; Ming Zhou; Chao Cao; Kejing Tang; Zhengguo Li; Dairong Li; Zhihong Zhang; Jie Li; Jianya Zhou; Hongzhong Yang; Yingying Du; Hui Yang; Jian Shi; Hualin Chen; Wenting Li; Dongmei Lu; Mingxiu Hu; Zhongmin Maxwell Wang; Baiyong Li; Michelle Xia; Shun Lu

Optimizing mycophenolic acid exposure for reduced relapse risk in paediatric nephrotic syndrome: An observational cohort study 优化霉酚酸暴露以降低儿童肾病综合征复发风险：一项观察性队列研究

British Journal of Clinical Pharmacology

IF3

2025-10-08

PREAI

Yiting Cai; Baojing Liu; Lizhi Chen; Lu Zhang; Kejing Tang; Xiaoyun Jiang; Pan Chen

Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC 患者报告结局和症状进展时间来自PAPILLON研究：amivantamab联合化疗对比化疗作为表皮生长因子受体（EGFR）外显子20插入突变型晚期非小细胞肺癌的一线治疗

Lung Cancer

IF4.4

2025-10-03

PREAI

Luis Paz-Ares; Remi Veillon; Margarita Majem; Caicun Zhou; Ke-Jing Tang; Sang-We Kim; Gary Richardson; Nicolas Girard; Rachel E. Sanborn; Aaron S. Mansfield; Keunchil Park; Julia Schuchard; Joris Diels; Jan Sermon; Archan Bhattacharya; Patricia Lorenzini; Honeylet Wortman-Vayn; Roland E. Knoblauch; Trishala Agrawal; Mahadi Baig; Akira Ono; Joshua K. Sabari

Analysis of pulmonary adverse events associated with immune checkpoint inhibitors based on FAERS and VigiBase database 基于FAERS和VigiBase数据库的免疫检查点抑制剂相关肺部不良事件分析

European Journal of Pharmacology

IF4.7

2025-09-12

PREAI

Zi-Mu Li; Yi-Fan Zheng; Pei-Hang Xu; Ji-Yu Wang; Rong-ling He; Hui-Xia Li; Yu -Kun Kuang; Li-Hong Bai; Ke-Jing Tang

Single-cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia 单细胞转录组分析揭示了原始细胞异质性，并鉴定出t(8;21)急性髓系白血病中新的治疗靶点IKZF2。

British Journal of Haematology

IF3.8

2025-08-08

PREAI

Yu Liu; Wenbing Liu; Yihan Mei; Qianqian Huang; Xiaoyu Liu; Chengcai Guo; Manling Chen; Junli Mou; Shangshang Wang; Wanqing Xie; Zheng Tian; Kejing Tang; Haiyan Xing; Ying Wang; Hui Wei; Runxia Gu; Qing Rao; Min Wang; Shaowei Qiu; Jianxiang Wang

The management of imatinib-associated severe skin rash in gastrointestinal stromal tumor: desensitization therapy and pharmacogenetic investigation 伊马替尼相关严重皮肤皮疹在胃肠道间质瘤中的管理：脱敏治疗和药物基因组学调查

ONCOLOGIST

IF4.2

2025-07-01

OAAI

Liu, Xiaoman; Pi, Mengying; Chen, Mukai; Cai, Shirong; He, Yulong; Tang, Ke-Jing; Zhang, Xinhua; Xia, Yanzhe

Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity (vol 31, pg 1003, 2024)激活固有免疫反应能重新极化人源性胚胎干细胞衍生的CAR巨噬细胞，以增强抗肿瘤活性（卷31，页1003，2024）

CELL STEM CELL

IF20.4

2025-05-01

PREAI

Shen, Jun; Lyu, Shuzhen; Xu, Yingxi; Zhang, Shuo; Li, Li; Li, Jinze; Mou, Junli; Xie, Leling; Tang, Kejing; Wen, Wei; Peng, Xuemei; Yang, Ying; Shi, Yu; Li, Xinjie; Wang, Min; Li, Xin; Wang, Jianxiang; Cheng, Tao

Reply to: Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes 回复：扩大霉酚酸在儿童狼疮肾炎中的角色：一种全面的方法，涉及肾外表现、副作用和长期结局

Seminars in Arthritis and Rheumatism

IF4.4

2025-04-17

PREAI

Lu Zhang; Lizhi Chen; Baojing Liu; Xiaohong Liu; Zhijun Huang; Kejing Tang; Xiaoyun Jiang; Pan Chen

IL-17A, IL-23R, FCGR3A are associated with neuropsychiatric systemic lupus erythematosus susceptibility in pediatric patients with lupus nephritis IL-17A、IL-23R、FCGR3A与狼疮性肾炎患儿神经精神狼疮易感性相关

CYTOKINE

IF3.7

2025-04-01

PREAI

Ye, Chen; Chen, Lizhi; Zhang, Lu; Zheng, Yifan; Liu, Xiaohong; Huang, Zhijun; Tang, Kejing; Jiang, Xiaoyun; Chen, Pan

Exposure-response relationship of mycophenolic acid in pediatric lupus nephritis patients receiving multi-target therapy: An observational cohort study 霉酚酸在儿科狼疮肾炎患者接受多靶点治疗中的暴露-反应关系：一项观察性队列研究

SEMINARS IN ARTHRITIS AND RHEUMATISM

IF4.4

2025-02-01

PREAI

Chen, Lizhi; Zhang, Lu; Liu, Baojing; Liu, Xiaohong; Huang, Zhijun; Tang, Kejing; Chen, Pan; Jiang, Xiaoyun

Dysfunction in mitochondrial electron transport chain drives the pathogenesis of pulmonary arterial hypertension: insights from a multi-omics investigation 线粒体电子传递链功能障碍驱动肺动脉高压的发病机制：多组学研究见解

RESPIRATORY RESEARCH

IF5

2025-01-20

OAAI

Zhang, Xin; Li, Jieling; Fu, Minyi; Geng, Xijie; Hu, Junjie; Tang, Ke-Jing; Chen, Pan; Zou, Jianyong; Liu, Xiaoman; Zeng, Bo

Liquid chromatography-tandem mass spectrometry for the quantification of ripretinib and its metabolites DP-5439 in human plasma 液相色谱-串联质谱法用于ripretinib及其代谢物DP-5439在人体血浆中的定量分析

FRONTIERS IN PHARMACOLOGY

IF4.8

2025-01-06

OAAI

Lin, Jiahui; Jiang, Aiting; Zheng, Juntao; Wu, Jingjing; Li, Hao; Cai, Shirong; He, Yulong; Chen, Xiao; Zhong, Guoping; Tang, Ke-Jing; Xia, Yanzhe

Mapping T-ALL to T Cell Differentiation Trajectory Identifies an ETP-like Subgroup Arrested at an Early Stage of T Cell Development 将T-ALL映射到T细胞分化轨迹，识别出一个在T细胞发育早期阶段停滞的ETP样亚群

BLOOD

IF23.1

2024-11-05

PREAI

Yu, Heye; Liu, Wenbing; Zhang, Junping; Xie, Leling; Lai, Anli; Tian, Zheng; Tang, Kejing; Xing, Haiyan; Ying, Wang; Wei, Hui; Rao, Qing; Gu, Runxia; Wang, Min; Wang, Huijun; Wang, Jianxiang; Qiu, Shaowei

The dynamic evolution of lineage switch under CD19 CAR-T treatment in non-KMT2A rearranged B-ALL patients

LEUKEMIA

IF13.4

2024-10-31

PREAI

Qiu, Shaowei; Mei, Yihan; Gu, Runxia; Liu, Yu; Chen, Manling; Xing, Haiyan; Tang, Kejing; Tian, Zheng; Rao, Qing; Yang, Donglin; Pang, Aiming; Wei, Shuning; Jia, Yujiao; Wang, Huijun; Feng, Sizhou; Wei, Hui; Zhu, Ping; Wang, Min; Wang, Ying; Liu, Wenbing; Wang, Jianxiang

研究方向